AIG-onco5

N/A

Report date: 2024/02/21 18:00:49
NME

Base Information

Drug NameAIG-onco5
Drug Alias NameAIG-onco5
ClassificationOther
Mechanisms of ActionTranscription factors inhibitors
TargetsTranscription factors
Therapy Area/IndicationsLung Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAIGEN Sciences Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsLung Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A